PLIANT THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
PLIANT THERAPEUTICS, INC. (PLRX) reported Increase (Decrease) in Other Noncurrent Assets of -$131.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-11
- PLIANT THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $192.00K.
- PLIANT THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$323.00K.
- PLIANT THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- PLIANT THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $0.00.
- PLIANT THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$43.00K, a 200.00% decline from fiscal 2024.
- PLIANT THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $43.00K.
- PLIANT THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $0.00.
- PLIANT THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was -$201.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$131.00K 10-Q · filed 2026-08-11 | -$131.00K derived: sum of 3 quarters · filed 2026-08-11 | -$131.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$323.00K 10-Q · filed 2026-05-11 | -$323.00K derived: sum of 2 quarters · filed 2026-05-11 | -$323.00K derived: sum of 3 quarters · filed 2026-05-11 | -$358.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | -$35.00K derived: sum of 3 quarters · filed 2026-08-11 | -$43.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$35.00K derived: sum of 2 quarters · filed 2026-08-11 | -$43.00K 10-Q · filed 2025-11-06 | -$35.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$43.00K 10-Q · filed 2026-08-11 | -$35.00K derived: sum of 3 quarters · filed 2026-08-11 | -$45.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$8.00K 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | -$10.00K derived: sum of 3 quarters · filed 2026-05-11 | $35.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$2.00K derived: sum of 2 quarters · filed 2026-03-11 | $43.00K derived: sum of 3 quarters · filed 2026-03-11 | $43.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $35.00K derived: sum of 2 quarters · filed 2025-11-06 | $35.00K 10-Q · filed 2025-11-06 | $402.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $45.00K 10-Q · filed 2025-08-07 | $412.00K derived: sum of 3 quarters · filed 2025-08-07 | $45.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $367.00K derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-05-08 | $0.00 derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $367.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 |
| 2023-09-30 | -$367.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$367.00K derived: sum of 2 quarters · filed 2024-11-07 | -$367.00K 10-Q · filed 2024-11-07 | -$127.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $240.00K derived: sum of 3 quarters · filed 2025-03-03 | -$201.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $240.00K derived: sum of 2 quarters · filed 2025-03-03 | -$201.00K derived: sum of 3 quarters · filed 2025-03-03 | $6.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$201.00K derived: sum of 2 quarters · filed 2025-03-03 | $6.00K derived: sum of 3 quarters · filed 2025-03-03 | -$201.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | -$441.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$234.00K derived: sum of 2 quarters · filed 2023-11-09 | -$441.00K 10-Q · filed 2023-11-09 | -$891.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | -$450.00K derived: sum of 3 quarters · filed 2024-02-27 | -$70.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$207.00K 10-Q · filed 2023-05-09 | -$657.00K derived: sum of 2 quarters · filed 2024-02-27 | -$277.00K derived: sum of 3 quarters · filed 2024-02-27 | -$277.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$450.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$70.00K derived: sum of 2 quarters · filed 2024-02-27 | -$70.00K derived: sum of 3 quarters · filed 2024-02-27 | -$70.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $380.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $380.00K derived: sum of 2 quarters · filed 2022-11-08 | $380.00K 10-Q · filed 2022-11-08 | $380.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $0.00 derived: sum of 3 quarters · filed 2022-08-08 | $0.00 derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2022-05-09 | $0.00 derived: sum of 3 quarters · filed 2022-05-09 | $303.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $303.00K derived: sum of 3 quarters · filed 2022-03-01 | $70.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $303.00K derived: sum of 2 quarters · filed 2021-11-09 | $70.00K 10-Q · filed 2021-11-09 | -$250.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $70.00K 10-Q · filed 2021-08-09 | -$250.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$233.00K 10-Q · filed 2021-05-10 | -$553.00K derived: sum of 2 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$232.00K 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $88.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |